SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who do not have diabetes.

Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules | Psychedelic Invest

VANCOUVER, British Columbia, May 29, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed GMP psychedelics pharmaceutical manufacturer,

May 29, 2024

15 States Sue to Block Biden’s Plan to Help ‘Dreamers’ Get Health Coverage

Fifteen states filed a federal lawsuit Thursday against the Biden administration over a rule that is expected to allow 100,000 immigrants brought to the U.S.

August 10, 2024

Solving the Nursing Shortage: Incredible Health’s AI Driven Platform

What You Should Know: – Incredible Health, the largest career marketplace for permanent healthcare workers, today announced new features available through its software and AI-powered

December 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.